Skip to main content

Table 2 Clinical characteristics of patients with KPLA stratified by non-diabetic and diabetic with optimal glycemic control

From: The emergence of Klebsiella pneumoniae liver abscess in non-diabetic patients and the distribution of capsular types

 

Non-DM

(n = 120)

DM with HbA1c < 7 %

(n = 19)

p

Age in years

64.1 ± 16.3

69.5 ± 12.9

0.166

Male

69 (57.5)

13 (68.4)

0.369

Charlson score

1.1 ± 1.8

2.0 ± 1.4

0.047

Underlying disease

 Malignancy

11 (9.2)

3 (15.8)

0.408

 Alcoholism

4 (3.3)

0 (0)

1.000

 Chronic kidney disease

4 (3.3)

3 (15.8)

0.054

 Liver cirrhosis

5 (4.2)

0 (0)

1.000

 Congestive heart failure

8 (6.7)

2 (10.5)

0.627

 Chronic lung disease

5 (4.2)

1 (5.3)

0.593

 Cerebrovascular accident

11 (9.2)

0 (0)

0.361

 APACHE II score

12.3 ± 6.9

14.9 ± 8.4

0.136

 Capsular type K1 and K2

94 (81.7)a

12 (75.0)b

0.506

 Wild-type antibiotic susceptibility

113 (94.2)

17 (89.5)

0.355

Origin

1.000

 Cryptogenic

103 (85.8)

17 (89.5)

 Biliary tract origin

17 (14.2)

2 (10.5)

Abscess location

0.937

 Right lobe

77 (64.2)

12 (63.2)

 Left lobe

21 (17.5)

4 (21.1)

 Both lobes

22 (18.3)

3 (15.8)

Abscess size

0.369

 <5 cm

51 (42.5)

6 (31.6)

 ≥5 cm

69 (57.5)

13 (68.4)

Gas-forming abscess

2 (1.7)

3 (15.8)

0.018

Multiple abscesses

18 (15.0)

3 (15.8)

1.000

Metastatic infection

6 (5.0)

1 (5.3)

1.000

Outcomes

 ICU admission

23 (19.2)

3 (15.8)

1.000

 Hospital days

26.9 ± 16.5

28.1 ± 21.1

0.786

 Mortality

4 (3.4)

0 (0)

1.000

  1. Data are presented as mean ± SD or frequency with percentage (%)
  2. a115 isolates were available for genotyping
  3. b16 isolates were available for genotyping